Last updated:
ID:
81410
Start date:
22 February 2022
Project status:
Closed
Principal investigator:
Dr Thomas van Sloten
Lead institution:
Maastricht University Medical Center, Netherlands

Individuals with diabetes have a higher risk of developing depression compared to individuals without diabetes. The extent to which this excess risk may be reduced by current treatment is unclear. Current treatment consists of targeting multiple factors, including high blood sugar levels, elevated blood pressure, being overweight, smoking and elevated protein levels in urine. In this project, we will evaluate to which extent the risk of depression in diabetes may be potentially mitigated by this multifactorial treatment. This will inform patients and medical doctors about the potential beneficial effects of current treatments. The estimated project duration is 12 months.

Related publications

Author(s)
April C E van Gennip, Miranda T Schram, Sebastian Köhler, Abraham A Kroon, Annemarie Koster, Simone J P M Eussen, Bastiaan E de Galan,…
Journal
The Lancet Healthy Longevity
  • mental health
  • nutrition and metabolism

All publications